Sign In
Buy AZN
$183.02
+2.00 (+1.10%)
At Close: Jun 24, 2026
TOKYO & BASKING RIDGE, N.J.--(BUSINESS WIRE)--A pooled analysis of the TROPION-Lung05 phase 2 and the TROPION-Lung01 phase 3 trials showed datopotamab deruxtecan (Dato-DXd) demonstrated clinically mea
AstraZeneca's Imfinzi Gets FDA Nod for Expanded Use in SCLC
11:05am, Thursday, 05'th Dec 2024
The FDA approves AZN's Imfinzi for treating patients with limited-stage small-cell lung cancer based on phase III ADRIATIC study data.
Here's Why Astrazeneca (AZN) is a Strong Momentum Stock
10:50am, Thursday, 05'th Dec 2024
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
AstraZeneca PLC (AZN) Shareholders May Have Been Affected by Fraud- Levi & Korsinsky Investigates
07:25am, Thursday, 05'th Dec 2024
NEW YORK, NY / ACCESSWIRE / December 5, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of AstraZeneca PLC ("AstraZeneca PLC") (NASDAQ:AZN) concerning possible violat
US regulator approves AstraZeneca's Imfinzi for small cell lung cancer
03:47am, Thursday, 05'th Dec 2024
AstraZeneca PLC's (LSE:AZN) Imfinzi (durvalumab) has received approval from the U.S. Food and Drug Administration (FDA) as the first immunotherapy treatment for limited-stage small cell lung cancer (L
FDA approves AstraZeneca's Imfinzi for limited-stage small cell lung cancer
05:55pm, Wednesday, 04'th Dec 2024
The U.S. Food and Drug Administration has approved AstraZeneca blockbuster drug Imfinzi to treat some adults with limited-stage small cell lung cancer, the health regulator said on Wednesday.
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of AstraZeneca PLC (AZN) on Behalf of Investors
04:00pm, Wednesday, 04'th Dec 2024
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of AstraZeneca PLC (“AstraZeneca” or the “Company”) (NASDAQ: AZN) investors concerning the C
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of AstraZeneca PLC (AZN) on Behalf of Investors
02:39pm, Wednesday, 04'th Dec 2024
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of AstraZeneca P
AstraZeneca names new international Executive VP to succeed Leon Wang
09:21am, Wednesday, 04'th Dec 2024
AstraZeneca said on Wednesday Iskra Reic will become its new international executive vice president succeeding Leon Wang, who was detained by Chinese authorities in October.
Levi & Korsinsky Investigates Possible Securities Fraud Violations by AstraZeneca PLC (AZN)
08:00pm, Tuesday, 03'rd Dec 2024
NEW YORK, NY / ACCESSWIRE / December 3, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of AstraZeneca PLC ("AstraZeneca PLC") (NASDAQ:AZN) concerning possible violat
The Law Offices of Frank R. Cruz Announces Investigation of AstraZeneca PLC (AZN) on Behalf of Investors
07:49pm, Tuesday, 03'rd Dec 2024
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of AstraZeneca PLC (“AstraZeneca” or the “Company”) (NASDAQ: AZN) on behalf of investors concerning th
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AstraZeneca PLC - AZN
07:23pm, Tuesday, 03'rd Dec 2024
NEW YORK , Dec. 3, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of AstraZeneca PLC ("AstraZeneca" or the "Company") (NASDAQ: AZN). Such investors are advised
3 Best Growth Stocks To Buy Now
12:35pm, Tuesday, 03'rd Dec 2024
Finding the “best” growth stocks to buy really is a subjective task, isn't it?
Novo Nordisk and AstraZeneca top of the 2025 drug picks for US investment bank - read why
06:36am, Tuesday, 03'rd Dec 2024
Success in 2025 for the pharma sector will hinge on the success of key drug pipeline developments, according to JPMorgan's latest research. With concerns over US drug pricing policies easing and sig
NEW YORK, NY / ACCESSWIRE / November 29, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of AstraZeneca PLC ("AstraZeneca PLC") (NASDAQ:AZN) concerning possible viola
